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HOSPITAL VARIATION IN ADMISSION TO INTENSIVE CARE UNITS FOR PATIENTS WITH 
MYOCARDIAL INFARCTION. RuiJun Chen, Kelly M. Strait, Kumar Dharmarajan, Shu-Xia Li, 
Isuru Ranasinghe, John Martin, Reza Fazel, Frederick A. Masoudi, Colin R. Cooke, Brahmajee K. 
Nallamothu, and Harlan M. Krumholz. Section of Cardiovascular Medicine, Department of Internal 
Medicine, Yale University, School of Medicine, New Haven, CT. 
 
The treatment of patients with myocardial infarction was transformed by the introduction of 
intensive care units (ICUs), but we know little about how contemporary hospitals employ this 
resource-intensive setting and whether higher use is associated with better outcomes. We sought 
to determine the variation in the rates of ICU admission across hospitals for patients with 
myocardial infarction and whether these rates were associated with mortality or usage of critical 
care therapies. We hypothesized that large variations exist in rates of ICU use for these patients 
across hospitals, but that these differences would not be associated with in-hospital mortality. We 
identified 114,980 adult hospitalizations for acute myocardial infarction from 311 hospitals in the 
2009-10 Premier database using codes from the International Classification of Diseases, Ninth 
Revision, Clinical Modification. Hospitals were stratified into quartiles by rates of ICU admission 
for patients with myocardial infarction. Across quartiles, we examined in-hospital risk-
standardized mortality rates and usage rates of critical care therapies for these patients. Rates of 
ICU admission for patients with myocardial infarction varied markedly among hospitals (median 
48%, IQR 35%-61%, range 0%-98%) and there was no association with in-hospital risk-
standardized mortality rates (6% all quartiles; p=0.7). However, hospitals admitting more patients 
to the ICU were more likely to use critical care therapies overall (mechanical ventilation [from 
Quartile 1 with lowest rate of ICU use to Quartile 4 with highest rate: 13% to 16%], 
vasopressors/inotropes [17% to 21%], intra-aortic balloon pumps [4% to 7%], and pulmonary 
artery catheters [4% to 5%]; p for trend<0.05 in all comparisons). Rates of ICU admission for 
myocardial infarction vary substantially across hospitals and were not associated with differences 
in mortality, but were associated with greater use of critical care therapies.  
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Introduction 
Contemporary intensive care units transformed the care of patients with 
myocardial infarction at a time when few effective therapies were available. The 
concept of the intensive observation of critically ill patients with readily available, 
specialized interventions is an idea deeply rooted in history, which has been 
referenced in writings throughout numerous civilizations dating back to ancient 
Egypt.1 The modern implementation of intensive care in the United States began 
in the 1920s, with a 3 bed unit for postoperative neurosurgical patients at the 
Johns Hopkins Hospital. However, intensive care units gained little traction until 
this concept of a specialized unit for the critically ill and the development of novel 
life-sustaining technologies coalesced in the late 1950s.2 This technological 
revolution included new machines capable of positive pressure ventilation, 
spurred by the polio epidemic, dialysis, external defibrillators, synchronized 
cardioversion, and even the less technologically advanced yet vital conception of 
external cardiopulmonary resuscitation techniques.3  
Once hospitals began widely adopting intensive care units in the early 
1960s and rapidly specialized into the development of coronary care units, 
patients with myocardial infarctions finally had readily available access to 
continuous electrocardiographic monitoring, invasive or resuscitative 
technologies, and higher nursing to patient ratios.4,5 Their initial adoption 
improved outcomes for these patients in an era when short-term mortality rates 
were high and complications such as post-infarction ventricular arrhythmias were 
common. Several studies showed that patients with acute myocardial infarctions 
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who were triaged to an intensive care unit had approximately 20% lower mortality, 
notably decreasing from 26% to 7% in the Killip’s landmark study of 250 patients 
over 2 years.6,7 As a result, approximately 60% of all hospitals in the United 
States had a coronary care unit within the next 10 years, and routine admission 
to an intensive care unit was quickly and widely accepted as the standard of care 
for most patients with myocardial infarction.8 This standard has continued to be 
strongly endorsed by clinical practice guidelines into the modern era, as recent 
American College of Cardiology and American Heart Association guidelines prior 
to 2013 strongly recommended admission to a critical care unit for all patients 
with an ST-elevation myocardial infarction as well as those with a non ST-
elevation myocardial infarction and “active, ongoing ischemia/injury or 
hemodynamic or electrical instability.9,10 These represented Class I 
recommendations, the highest recommendation level possible, but held only a 
level of evidence C, indicating that they were based on expert opinion rather than 
modern supporting evidence. 
Today, given the marked evolution in the clinical care and evidence base 
for myocardial infarction, the value of intensive care units for many of these 
patients in contemporary practice warrants closer scrutiny. Non-critical care 
wards now possess the capability to provide telemetry monitoring and advanced 
therapies previously limited to intensive care units, such as the administration of 
intravenous anti-arrhythmic agents.2,11 Simultaneously, the prognosis of patients 
with myocardial infarction has substantially improved as ST-segment elevation 
myocardial infarctions, complications including shock and heart failure, and short-
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term mortality have all declined, raising questions about which contemporary 
patients truly benefit from being in an intensive care unit.12-17 Finally, intensive 
care units are not only increasingly expensive, as they account for only 5-10% of 
total beds but 20-34% of nationwide hospital costs,18,19 but also facilitate the 
implementation of resource-intensive strategies that, while essential for some 
patients, may be discretionary in others.20-22 In part because of uncertainty about 
the marginal benefit of intensive care units for many patients, the most recent 
version of the American College of Cardiology and American Heart Association 
guidelines on myocardial infarction no longer contain specific recommendations 
on intensive care unit use.23,24 Meanwhile, little is known about how hospitals use 
this resource and whether higher rates of intensive care unit use are associated 
with better outcomes.  
 
Purpose, Hypothesis, and Aims 
Accordingly, we sought to describe hospital variation in the use of 
intensive care units and associated outcomes for patients with myocardial 
infarction in a large contemporary sample of hospitals in the United States. We 
hypothesized that large variations would exist in the rates of intensive care unit 
use for these patients across hospitals, but that these differences in use would 
not be associated with any differences in in-hospital mortality. Further, we 
explored the relationship between hospital rates of intensive care unit use and 
the utilization of resource-intensive treatment strategies in the overall cohort of 
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patients with myocardial infarction and the subset of these patients admitted to 
an intensive care unit. 
 
Methods  
Data Source 
We conducted a retrospective cohort study using a voluntary, fee-
supported database maintained by Premier, Inc. for measuring quality and 
healthcare utilization. Through 2010, the Premier database contained data on 
more than 325 million cumulative hospital discharges, with over 90 million 
discharges from 2009-2010 alone, representing approximately 1 out of every 5 
hospital discharges nationwide. In addition to information available in standard 
hospital discharge files, this database contains a date-stamped log of all billed 
items at the patient level including diagnostic tests, medications, and therapeutic 
services. Patient data were de-identified in accordance with the Health Insurance 
Portability and Accountability Act and a random hospital identifier assigned by 
Premier was used to identify the hospitals. The Yale University Human 
Investigation Committee reviewed the protocol for this study and determined that 
it is not considered to be Human Subjects Research as defined by the Office of 
Human Research Protections. 
 
Study Population 
We included all hospitalizations from January 1, 2009 to December 31, 
2010 for patients aged 18 years or older with a principal discharge diagnosis of 
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acute myocardial infarction as defined by the International Classification of 
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes 410.xx. We 
excluded ICD-9-CM codes representing subsequent episodes of care (410.x2) 
and all hospitalizations involving transfers, as we could not link hospitalizations 
across different institutions and would be unable to capture their full hospital 
course. Furthermore, we excluded hospitals with fewer than 25 admissions for 
myocardial infarction over the study period to decrease the likelihood of 
artifactual findings from small sample sizes. We also excluded hospitals with no 
intensive care unit hospitalizations for myocardial infarction to ensure that 
hospitals would not lack an intensive care unit as an option for hospitalized 
patients.  
 
Study Variables 
Intensive Care Unit Admission Rates. For each hospital, we identified 
the proportion of hospitalizations for acute myocardial infarction that were directly 
admitted to an intensive care unit. We defined direct admission to an intensive 
care unit as having a room and board charge for a medical, coronary, surgical, or 
general intensive care unit bed during the first hospital day. We did not include 
step-down units due to the lack of reliability in coding for these beds as well as 
the lack of availability of step-down units in a significant proportion of hospitals. 
We then assessed intensive care unit admission patterns among four distinct 
subgroups of hospitalizations for myocardial infarction: 1) patients with ST-
segment elevation myocardial infarctions, 2) patients with non-ST-segment 
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elevation myocardial infarctions, 3) patients receiving reperfusion therapy, and 4) 
patients not receiving reperfusion therapy. We chose to study variation further 
across these subgroups due to the possibility that these patients may differ in 
their acuity of illness and/or their monitoring needs. ST-segment elevation 
myocardial infarctions were identified using ICD-9-CM codes 410.0 through 
410.8 (excluding 410.7).12 Non-ST-segment elevation myocardial infarctions 
were identified using ICD-9-CM code 410.7.25 Reperfusion therapy was defined 
as either thrombolysis or percutaneous coronary intervention provided at any 
time during hospitalization. 
 
Mortality. For each hospital, we calculated in-hospital all-cause risk-
standardized mortality rates for 1) all patients with myocardial infarction and 2) 
intensive care unit patients with myocardial infarction—defined as the subset of 
all patients with myocardial infarction who were directly admitted to an intensive 
care unit. 
 
Use of Critical Care Therapy. For each hospital, we calculated the use of 
critical care therapies among 1) all patients with myocardial infarction and 2) 
intensive care unit patients with myocardial infarction. For these outcomes, we 
hypothesized that hospitals with higher rates of intensive care unit use would be 
more likely to use critical care therapies in their overall cohort of patients with 
myocardial infarction due to greater discretionary use and a gatekeeper effect 
granting more patients access to such therapies. In contrast, we postulated such 
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therapies would be less likely to be used in their intensive care unit patient 
subgroups due to a higher proportion of low-risk patients in the intensive care 
unit. Critical care therapies were defined as therapies for myocardial infarction 
that are typically available only in an intensive care unit, including the use of 
mechanical ventilation, intravenous vasopressors or inotropes, intra-aortic 
balloon pumps, and/or pulmonary artery catheters.  
 
Length of Stay. For each hospital, we calculated the length of stay for 1) 
all patients with myocardial infarction and 2) intensive care unit patients with 
myocardial infarction.  
 
Statistical Analysis 
Results for categorical variables are reported as percentages. Results for 
continuous variables are reported with medians and interquartile ranges. 
Hospitals were categorized into quartiles based on the proportion of all 
hospitalizations for myocardial infarction admitted to an intensive care unit, with 
the top quartile (quartile 4) having the highest rates of admission and the bottom 
quartile (quartile 1) having the lowest rates. Hospital characteristics, mortality, 
critical care therapies, and length of stay were assessed across quartiles.  
For 1) all patients with myocardial infarction and 2) intensive care unit 
patients with myocardial infarction, we calculated in-hospital risk-standardized 
mortality rates for each hospital using hierarchical logistic regression, employing 
methods that are used in the outcomes measures publicly reported by the 
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Centers for Medicare & Medicaid Services.26,27 We adjusted for patient 
characteristics including age and comorbidities (Table 1) classified using the 
software provided by the Healthcare Costs and Utilization Project of the Agency 
for Healthcare Research and Quality.28 Variables were selected using a stepwise 
algorithm.  
Table 1. Selected Comorbidities. 
Covariates 
Used in ICU 
Patient Model 
Used in Overall 
Patient Model 
Age (categorical) X X 
Congestive heart failure X X 
Pulmonary circulation disease X  
Peripheral vascular disease X X 
Paralysis  X 
Other neurological disorders X X 
Chronic pulmonary disease  X 
Diabetes with or without chronic complications X X 
Hypothyroidism X X 
Renal failure X  
Liver disease X X 
Metastatic cancer X X 
9 
 
 
 
Solid tumor without metastasis X X 
Coagulopathy X X 
Obesity  X 
Weight loss X X 
Fluid and electrolyte disorders X X 
Chronic blood loss anemia X X 
Deficiency anemias X X 
Drug abuse X X 
Psychoses X  
Depression X X 
Hypertension X X 
  ICU, intensive care unit 
 
We examined the relationship between intensive care unit admission rates and 
risk-standardized mortality rates using a scatterplot and also compared mortality 
rates across quartiles. Next, we compared the median length of stay across the 
four quartiles. A Kruskal-Wallis test was used to assess statistical significance in 
both the mortality rate and length of stay comparison. We then compared the rate 
of critical care therapy use across quartiles. A Cochran-Armitage Trend test was 
used to assess statistical differences in therapy use across quartiles. We 
considered p-values <0.05 as statistically significant.  
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Analyses were conducted with SAS version 9.3 (SAS Institute Inc., Cary, 
NC). The GLIMMIX procedure was used to estimate the hierarchical logistic 
models. We generated the figures with R version 2.9.1 (R Development Core 
Team, Vienna, Austria).29 The statistical analysis on SAS as well as the 
acquisition of the Premier database was performed by other members of the 
research team. I was involved in the interpretation of the data and the design of 
the study, including decisions on aims, study variables, primary and secondary 
analyses, and statistical tests. 
 
Results 
Hospital Characteristics 
We identified 114,136 hospitalizations for myocardial infarction in the 307 
hospitals which admitted patients to an intensive care unit over the 2-year study 
period. Of these hospitalizations, 54,527 (48%) involved admission to an 
intensive care unit on the first hospital day. Among hospitals, the median bed 
size was 302 (interquartile range: 186,432), median 2-year volume of 
hospitalizations for myocardial infarction was 258 (interquartile range: 84,539), 
and median 2-year volume of intensive care unit hospitalizations for myocardial 
infarction was 112 (interquartile range: 34,265). Hospitals in our study tended to 
be located in the South (39%), serve an urban population (83%), and identify as 
non-teaching (71%; Table 2).  
Following stratification into quartiles by intensive care unit admission rates 
for patients with myocardial infarction, quartile 1 included hospitals with intensive 
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care unit admission rates ≤34%. Quartile 2 included hospitals with rates of 35%-
48%. Quartile 3 included hospitals with rates of 49%-61%. Quartile 4 included 
hospitals with rates ≥ 62%. Across quartiles, hospitals had similar 
characteristics except that those with the lowest intensive care unit admission 
rates (quartile 1) were smaller (42% had ≤200 beds compared with 28%, 22%, 
and 20% in quartiles 2, 3, and 4, respectively) and had a lower 2-year case 
volume of myocardial infarctions (38% had <85 hospitalizations for AMI 
compared with 25%, 15% and 22% in quartiles 2, 3, and 4, respectively).  
Table 2. Hospital Cohort Characteristics (N=307) 
 
All 
Hospitals 
(n=307) 
n(%) 
Quartile 1 
(n=77) 
n(%) 
Quartile 2 
 (n=76) 
n(%) 
Quartile 3 
(n=78) 
n(%) 
Quartile 4 
(n=76) 
n(%) 
Number of beds     
1 – 200 85 (28) 32 (42) 21 (28) 17 (22) 15 (20) 
201 – 400 130 (42) 27 (35) 36 (47) 31 (40) 36 (47) 
401 – 600 64 (21) 14 (18) 14 (18) 19 (24) 17 (22) 
>600 28 (9) 4 (5) 5 (7) 11 (14) 8 (11) 
Volume of hospitalizations for acute MI*    
25* – 84 77 (25) 29 (38) 19 (25) 12 (15) 17 (22) 
85 – 258 77 (25) 17 (22) 21 (28) 18 (23) 21 (28) 
259 – 539 77 (25) 15 (19) 19 (25) 21 (27) 22 (29) 
>539 76 (25) 16 (21) 17 (22) 27 (35) 16 (21) 
Volume of ICU hospitalizations for acute MI*   
1 – 34 79 (25) 43 (56) 18 (24) 9 (12) 9 (12) 
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35 – 112 75 (25) 17 (22) 23 (30) 16 (21) 19 (25) 
113 – 265 77 (25) 16 (21) 22 (29) 21 (27) 19 (24) 
>265 76 (25) 1 (1) 13 (17) 32 (41) 30 (39) 
Geographic region     
Midwest 74 (24) 19 (25) 17 (22) 13 (17) 25 (33) 
Northeast 49 (16) 17 (22) 12 (16) 13 (17) 7 (9) 
South 119 (39) 27 (35) 32 (42) 30 (38) 30 (40) 
West 65 (21) 14 (18) 15 (20) 22 (28) 14 (18) 
Population served     
Urban 254 (83) 60 (78) 62 (82) 68 (87) 64 (84) 
Rural 53 (17) 17 (22) 14 (18) 10 (13) 12 (16) 
Teaching status     
Non-teaching 219 (71) 54 (70) 55 (72) 55 (71) 55 (72) 
Teaching 88 (29) 23 (30) 21 (28) 23 (29) 21 (28) 
MI, myocardial infarction; ICU, intensive care unit 
*Categories were stratified by quartiles from the overall distribution of volume of 
hospitalizations for acute MI and ICU hospitalizations for MI. Volume was measured across 
the 2-year study period. 
 
 
Among patients, the proportion of hospitalizations for ST-segment elevation 
myocardial infarction ranged from 32% to 39% from quartile 1 to 4, while the 
proportion of hospitalizations utilizing reperfusion therapy ranged from 44% to 51% 
(Table 3). Other patient characteristics, including age, gender, and comorbidities 
were largely similar across quartiles. 
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Table 3. Patient Characteristics (n=114,136).  
 All Patients 
(n=114,136) 
(%) 
Quartile 1 
(n=24,576) 
(%) 
Quartile 2 
(n=25,904) 
(%) 
Quartile 3 
(n=38,121) 
(%) 
Quartile 4 
(n=25,535) 
(%) 
Age      
18 – 54 21 18 21 22 24 
55 – 64 23 20 22 23 24 
65 – 74 21 21 21 22 20 
75 – 84 20 22 21 20 19 
≥85 15 18 16 14 13 
Gender      
Male 60 59 60 61 61 
Female 40 41 40 39 39 
Type of Myocardial Infarction     
ST-Segment Elevation 37 32 36 38 39 
Non-ST-Segment 
Elevation 
63 68 64 62 61 
Reperfusion      
Yes 47 44 47 46 51 
No 53 56 53 54 49 
Comorbidities      
Peripheral Vascular 
Disease 
13 13 12 13 13 
Other Neurological 
Disorders 
7 7 7 7 6 
Chronic Pulmonary 
Disease 
21 21 21 21 20 
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Diabetes with and without 
Complications 
36 36 36 35 35 
Hypothyroidism 11 11 11 11 10 
Renal Failure 20 21 20 19 19 
Coagulopthy 5 5 5 5 6 
Obesity 13 13 13 14 13 
Fluid and Electrolyte 
Disorders 
22 23 21 23 23 
Deficiency Anemias 19 19 18 19 19 
Depression 8 8 8 8 7 
Hypertension 70 71 70 70 71 
 
Intensive Care Unit Admission Rates 
The intensive care unit admission rate for hospitalizations for myocardial 
infarction among hospitals varied markedly with a range from 0% to 98% (median: 
48%; interquartile range: 35-61%; Figure 1). The hospital with the lowest 
admission rate did not have an absolute rate of 0% but rather, this figure was 
obtained due to rounding. The median intensive care unit admission rates across 
quartiles 1 through 4 were 20%, 41%, 55%, and 71%, respectively, and 
demonstrate a sizeable increase in median admission rates from quartile 1 to 
quartile 2. 
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Figure 1. ICU Admission Rates across Hospitals for All Hospitalizations for 
Myocardial Infarction (N=307). Each data point represents a hospital; ICU, 
intensive care unit 
 
Among the subgroups, intensive care unit admission rates across 
hospitals within each patient group also varied widely despite differences in 
median overall intensive care unit admission rates across patient groups. There 
were 302 out of the 307 total hospitals which had patients with an ST-segment 
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elevation myocardial infarction admitted to an intensive care unit, while there 
were 306 out of the 307 total hospitals which had patients with a non ST-
segment elevation myocardial infarction admitted to an intensive care unit. The 
median intensive care unit admission rate for patients with ST-segment elevation 
myocardial infarction was 75% (range 0-100%, Figure 2), higher than the median 
admission rate for all patients with myocardial infarction, while the median rate 
for non-ST-segment elevation myocardial infarctions was 35% (range 0-96%, 
Figure 3), lower than the median admission rate for all patients with myocardial 
infarction.  
There were 221 out of the 307 total hospitals which admitted patients who 
underwent reperfusion therapy to an intensive care unit, while there were 306 out 
of the 307 total hospitals which admitted patients who did not undergo 
reperfusion therapy to an intensive care unit. The median intensive care unit 
admission rate for patients who received reperfusion therapy was 67% (range 0-
100%, Figure 4), which was higher than the median admission rate for all 
patients with myocardial infarction. The median rate for patients who did not 
receive reperfusion therapy was 38% (range 0-97%, Figure 5), lower than the 
median admission rate for all patients with myocardial infarction. Again, rates of 0% 
were obtained due to rounding rather than a lack of patients admitted to an 
intensive care unit. 
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Figure 2. ICU Admission Rates across Hospitals for Patients with STEMI 
(N=302). Hospitals with no patients admitted to an ICU with a STEMI are not 
represented; ICU, intensive care unit; STEMI, ST-segment elevation myocardial 
infarction. 
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Figure 3. ICU Admission Rates across Hospitals for Patients with NSTEMI 
(N=306). Hospitals with no patients admitted to an ICU with a NSTEMI are not 
represented; ICU, intensive care unit; NSTEMI, non ST-segment elevation 
myocardial infarction. 
19 
 
 
 
 
Figure 4. ICU Admission Rates across Hospitals for Patients with 
Myocardial Infarction Receiving Reperfusion Therapy (N=215). Hospitals with 
no patients admitted to an ICU with a myocardial infarction who received 
reperfusion therapy are not represented; ICU, intensive care unit. 
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Figure 5. ICU Admission Rates across Hospitals for Patients with 
Myocardial Infarction Not Receiving Reperfusion Therapy (N=306). Hospitals 
with no patients admitted to an ICU with a myocardial infarction who did not 
receive reperfusion therapy are not represented; ICU, intensive care unit. 
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Mortality 
There was no relationship between hospital intensive care unit admission 
rates and in-hospital risk-standardized mortality rates for all patients with 
myocardial infarction (Figure 6).  
 
Figure 6. Overall In-Hospital Risk-Standardized Mortality Rates across 
Hospital ICU Admission Rates for Myocardial Infarction (N=307). Each data 
point represents a hospital; ICU, intensive care unit 
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When compared across quartiles of intensive care unit admission, there 
was no statistical difference in risk-standardized mortality rates. Quartile 1 
hospitals had a collective mortality rate of 6.0% while hospitals in quartiles 2, 3, 
and 4 had collective mortality rates of 6.0%, 6.1%, and 5.9%, respectively (p=0.7; 
Table 4).  
Table 4. Risk-Standardized In-Hospital Mortality across Hospitals for All Patients with 
Myocardial Infarction (N=307). 
Outcome Category N Mortality rate (%) P-value 
Risk-standardized in-
hospital mortality 
Quartile 1  77 6.0 
0.73 
Quartile 2  76 6.0 
Quartile 3  78 6.1 
Quartile 4  76 5.9 
 
 
 
For the subgroup of intensive care unit patients with myocardial infarction, in-
hospital risk-standardized mortality rates differed significantly among quartiles. 
The hospitals with the highest intensive care unit admission rates had the lowest 
mortality (6.5% in quartile 4) while lower intensive care unit admission rates were 
associated with higher mortality (7.1%, 7.9%, and 8.7% in quartiles 3, 2, and 1, 
respectively; p<0.0001; Table 5).  
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Table 5. Risk-Standardized In-Hospital Mortality across Hospitals for ICU Patients with 
Myocardial Infarction (N=307). 
Outcome Category N Mortality rate (%) P-value 
Risk-standardized in-
hospital mortality 
Quartile 1  77 8.7 
<0.01 
Quartile 2 76 7.9 
Quartile 3  78 7.1 
Quartile 4  76 6.5 
  ICU, intensive care unit 
 
Use of Critical Care Therapy 
All Patients with Myocardial Infarction  
The proportion of all patients with myocardial infarction utilizing critical 
care therapies increased across quartiles of increasing hospital intensive care 
unit admission rates. From quartile 1 to 4, there was a significantly increasing 
trend in the use of mechanical ventilation from 13% to 16% (p<0.01), 
vasopressors or inotropes from 17% to 21% (p<0.01), intra-aortic balloon pumps 
from 4% to 7% (p<0.01), and pulmonary artery catheters from 4% to %5 (p=0.04; 
Table 6).  
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Table 6. Critical Care Therapy Utilization across Hospitals for All Patients with Myocardial 
Infarction (N=114,136) 
 
Therapy 
Usage of therapy 
(Proportion of hospitalizations utilizing therapy; %) 
P-value  
for Trend 
Quartile 1  
(n=24,576) 
Quartile 2  
(n=25,904) 
Quartile 3  
(n=38,121) 
Quartile 4  
(n=25,535) 
Mechanical ventilation 13 15 15 16 <0.01 
Vasopressors and/or 
inotropes 
17 18 20 21 <0.01 
Intra-aortic balloon pump 4 5 5 7 <0.01 
Pulmonary artery catheter 4 6 5 5 0.04 
 
Intensive Care Unit Patients with Myocardial Infarction 
Among the subgroup of intensive care unit patients with myocardial 
infarction, there was a significantly decreasing trend in the proportion of patients 
receiving critical care therapies across quartiles of increasing intensive care unit 
admission rates. From quartile 1 to 4, there was a decrease in the use of 
mechanical ventilation from 28% to 18%, vasopressors or inotropes from 35% to 
24%, intra-aortic balloon pumps from 12% to 9%, and pulmonary artery catheters 
from 6% to 5% (p<0.01 for all therapies; Table 7).  
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Table 7. Critical Care Therapy Utilization across Hospitals for ICU Patients with Myocardial 
Infarction (N=54,527) 
Therapy 
Usage of therapy 
(Proportion of hospitalizations utilizing therapy; %) 
P-value  
for Trend 
Quartile 1  
(n=4,860) 
Quartile 2  
(n=10,537) 
Quartile 3  
(n=20,940) 
Quartile 4  
(n=18,190) 
Mechanical ventilation 28 22 19 18 <0.01 
Vasopressors and/or 
inotropes 
35 26 25 24 <0.01 
Intra-aortic balloon pump 12 9 8 9 <0.01 
Pulmonary artery catheter 6 6 5 5 <0.01 
ICU, intensive care unit 
 
Length of Stay 
All Patients with Myocardial Infarction  
The median length of stay for all patients with myocardial infraction was 
largely similar across quartiles. Quartiles 1, 2, and 4 all had a median length of 
stay of 3 days, with an interquartile range of 2 to 6 days. Quartile 3 hospitals had 
the longest length of stay at 4 days but similarly had an interquartile range of 2 to 
6 days (p<0.0001; Table 8). 
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Table 8. Length of Stay across Hospitals for All Patients with Myocardial Infarction 
(N=114,980). 
Outcome Category N 
Length of Stay in days 
Median (IQR) 
P-value 
Length of Stay 
Quartile 1 24,576 3 (2, 6) 
<0.0001* 
Quartile 2 25,904 3 (2, 6) 
Quartile 3 38,121 4 (2, 6) 
Quartile 4 25,535 3 (2, 6) 
*Global test 
 
Intensive Care Unit Patients with Myocardial Infarction 
Among the subgroup of intensive care unit patients with myocardial 
infarction, there was a slight difference in length of stay across quartiles. Patients 
admitted to the intensive care unit with myocardial infarctions at quartile 4 
hospitals, those with the highest admission rates, had the shortest median length 
of stay at 3 days (interquartile range: 2, 6). Quartile 3 hospitals had a median 
length of 4 days (interquartile range: 2, 7), while quartile 2 hospitals had a 
median length of stay of 4 days (interquartile range: 2, 6). Quartile 1 hospitals, 
those with the lowest intensive care unit admission rates, had the longest median 
length of stay of 4 days (interquartile range: 3, 7; p<0.0001; Table 9). 
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Table 9. Length of Stay across Hospitals for ICU Patients with Myocardial Infarction 
(N=54,527). 
Outcome Category N 
Length of Stay in days  
Median (IQR) 
P-value 
Length of Stay 
Quartile 1 4,860 4 (3, 7) 
<0.0001* 
Quartile 2 10,537 4 (2, 6) 
Quartile 3 20,940 4 (2, 7) 
Quartile 4 18,190 3 (2, 6) 
*Global test; ICU, intensive care unit 
 
Discussion 
We found that intensive care unit admission rates for myocardial infarction 
varied substantially across hospitals but were not associated with differences in 
mortality after accounting for case mix. There was also little absolute difference 
in overall length of stay. Hospitals admitting a greater percentage of patients to 
the intensive care unit were more likely to perform invasive critical care 
interventions overall. However, the use of these interventions and length of stay 
was lower in these high-admitting hospitals among the subset of patients with 
myocardial infarction admitted directly to the intensive care unit, suggesting that 
at the margin, hospitals admitting a larger proportion of patients to the intensive 
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care unit were admitting a group of lower risk patients with weaker indications for 
these therapies.  
To our knowledge, this is the first study to examine hospital-level variation 
in intensive care unit utilization for myocardial infarction and its association with 
outcomes in such large sample of hospitals. Although intensive care may be 
providing lifesaving interventions for the appropriate patients, it may not be 
providing value for all patients admitted to an intensive care unit. The decision to 
use an intensive care unit is important not only because intensive care units are 
resource intensive settings,18 but also because these hospitalizations potentially 
pose numerous inherent risks for patients including but not limited to various 
sources of infection, venous thromboembolic disease, and delirium.30,31 Our 
findings suggest that we may not be optimally utilizing these highly specialized 
resources.  
 These findings highlight the decision to use an intensive care unit for 
patients with a myocardial infarction as a potential target for improvement. As 
early as 1987, Wagner noted a significant portion of the general intensive care 
unit population in hospitals were low-risk patients admitted for monitoring, of 
which only 4.3% received any critical care treatments, and called for a 
reassessment of contemporary intensive care unit utilization to guide optimization 
of use.32 More recent studies have shown little improvement in the landscape of 
intensive care utilization today, as more than half of patients directly admitted to 
intensive care units have a 30-day mortality of 2% or less.33 Furthermore, 
hospitals demonstrate significant variation in their utilization of intensive care unit 
29 
 
 
 
care for both all patients and patients with specific conditions such as acute 
decompensated heart failure and diabetic ketoacidosis.33-36 We extend this work 
to patients with myocardial infarction in a contemporary patient population. 
Compared with previous work on heart failure patients and the overall patient 
population, patients with myocardial infarction have a higher median hospital 
intensive care unit admission rate and wider variation across hospitals 
(interquartile range of 35-61% for patients with myocardial infarction versus 6-16% 
for heart failure patients and 4.7-10% or 9-17% for all patients).33-35 Such 
differences suggest that patients with myocardial infarction account for a 
relatively higher cost and resource burden on the healthcare system overall and 
high-admitting hospitals in particular, making this population a potentially high 
yield target for optimization.  
Our results suggest that variation across hospitals in intensive care unit 
triage may be more due to hospital factors rather than patient characteristics. For 
example, we found that patient demographics and comorbidities were 
comparable across the four quartiles of hospitals. Wide variations in rates of 
intensive care unit admission across hospitals were identified in all patient 
subgroups. This includes patients with ST-segment and non- ST-segment 
elevation myocardial infarctions, and patients who did and did not undergo 
reperfusion therapy, suggesting that no particular group was responsible for this 
overall hospital-level variation. Our findings are consistent with previous literature 
for other conditions suggesting that patient characteristics explain only a modest 
proportion of the variation in intensive care unit use.33 Despite efforts to 
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standardize patient care through published algorithms and guidelines, the lack of 
consistency in intensive care unit use likely still reflects a large discretionary 
component that includes consideration of bed availability, patients’ wishes, 
physician incentives, and differing beliefs about best practices, particularly across 
different institutions.34,37,38  
There are several possible explanations for our findings. First, hospitals 
admitting a large proportion of patients with myocardial infarction to the intensive 
care unit may have lower thresholds for intensive care unit admission, thereby 
using intensive care for lower-risk patients who are less likely to have adverse 
outcomes or need critical care therapies. Consistent with this hypothesis, we 
found a trend that intensive care unit patients with myocardial infarction were less 
likely to receive critical care interventions and had lower mortality at higher-
admitting hospitals. Also supporting this hypothesis, these intensive care unit 
patients at the highest-admitting hospitals also had the shortest median length of 
stay while the lowest-admitting hospitals had the longest length of stay. When 
considered in combination with the overall lack of difference in mortality, this 
further suggests that hospital patient-risk thresholds for admission to an intensive 
care unit may be very different between high- and low-admitting hospitals. An 
alternative explanation for this trend may be that high-admitting hospitals are 
improving patient outcomes with intensive care unit admission. However, this 
seems unlikely given that across quartiles, patient characteristics were similar 
and overall mortality rates for myocardial infarction did not differ despite such 
widely varying rates of intensive care unit and critical care therapy use.  
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Our results have important implications for health system leaders and 
policymakers seeking to improve the efficiency of inpatient care. This pattern of 
care for myocardial infarction in high-admitting hospitals—higher overall use of 
intensive care units and critical care therapies across all patients combined with 
the lower use of critical care therapies per intensive care unit patient—suggests 
an opportunity where improving triage could enhance resource utilization without 
undermining outcomes.  
Several strategies may provide practical approaches to improve use of the 
intensive care unit for patients with a myocardial infarction. At the provider level, 
a renewed emphasis may need to be placed on the use of appropriate risk 
stratification for patients with myocardial infarction at presentation. Well-validated 
risk prediction models exist to accurately predict in-hospital adverse cardiac 
outcomes, such as the well-known Global Registry of Acute Coronary Events 
(GRACE) and the Thrombolysis in Myocardial Infarction (TIMI) scores.39,40 Other 
studies have specifically identified clinical features and risk factors that predict 
complications and critical care needs.41 Low-risk patients identified with these 
tools have excellent in-hospital and long-term outcomes and therefore may not 
routinely require intensive care unit admission. Furthermore, for many patients 
admitted to intensive care units for monitoring and prevention of complications, 
intermediate care units such as step-down units or general telemetry units may 
provide an equally safe yet more cost-effective alternative. Finally, risk prediction 
models can also effectively guide admission to these units in an effort to optimize 
utilization and cost through a more gradated system of care.42  
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In addition to these strategies, future investigation should focus on better 
understanding the drivers of these hospital-level variations or phenotypes, the 
population of patients with myocardial infarction who most benefit from intensive 
care unit admission, and the point at which marginal benefit from intensive care 
unit admission ceases. A few studies have demonstrated that certain subsets of 
patients with acute myocardial infarction, such as low-risk patients who 
underwent successful reperfusion through percutaneous coronary intervention, 
have similar outcomes whether they are admitted to a general medicine ward or 
to an intensive care unit.10,20,22 However, more of these studies are needed in 
order to determine all of the patient subgroups, patient characteristics, and 
clinical markers which may influence whether or not intensive care admission can 
influence outcomes. Additional research utilizing clinical databases or registry 
may be the next steps in better understanding this distinction. In addition, 
detailed investigations utilizing both quantitative and qualitative methods to 
analyze various samples of hospitals from each of these quartiles of intensive 
care unit utilization may elucidate which hospital factors have the largest effect 
on dictating patient triage and allow us to better understand the discretionary 
components of use. 
Such investigations and future studies of these resource-intensive settings 
are particularly relevant as healthcare spending in the United States continues to 
escalate, gaining attention and notoriety in both the political arena and the public 
eye. Even as the economy has slowed in recent years, healthcare expenditures 
continued to grow each year, reaching $2.7 trillion in 2011.43 Intensive care 
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accounts for a substantial proportion of these expenditures, with costs exceeding 
$80 billion as of 2005 and growing.19 Recently, a significant amount of literature 
has focused on the need for effective and efficient use of critical care in order to 
maximize its value. Articles in prominent, high-impact journals have promoted the 
use of several multidisciplinary strategies to improve critical care utilization, 
including health information technology capitalizing on integrated health systems 
and electronic health records,44 as well as the economic concept of demand 
elasticity and the need to understand or control the influence of intensive care 
unit bed availability on utilization.45 These multidisciplinary, high-level 
approaches should go hand in hand with our suggested need to understand the 
hospital-level influences on discretionary use and varying institutional cultures, 
and complement potentially more granular approaches to optimizing critical care 
for high-value diseases such as myocardial infarction. 
Several factors should be considered in interpreting our results. Our study 
focused on hospital patterns so we cannot make an inference about the utility of 
admission to an intensive care unit for any particular patient. We performed 
hospital risk adjustment using age, sex, and comorbidities derived from 
administrative data. Although clinical data are typically superior to claims data for 
patient-level risk adjustment, claims-based hospital-level risk adjustment has 
been shown to produce similar results at the hospital level, particularly for 
myocardial infarctions.26,27 Our study also depended on the reliability of the 
administrative and billing data to distinguish between intensive care unit and non-
intensive care unit beds. However, due to the large discrepancy in billing costs 
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between these bed types, we feel confident that hospitals would ensure these 
billing codes are accurate as they potentially represent a significant difference in 
compensation. In addition, we were unable to apply a clinical risk score to assess 
the extent to which intensive care unit use was calibrated to patients’ underlying 
clinical risk. We were also unable to track patients after hospital discharge so 
longer-term outcomes could not be evaluated. Finally, our hospital cohort may 
not be representative of general intensive care unit triage patterns nationwide; 
however, the Premier network covers much of the United States.  
In conclusion, we revealed marked variation in intensive care unit 
admission across hospitals for patients admitted with myocardial infarction. We 
failed to find any relationship between more intensive use of intensive care units 
and better outcomes, even though aggressive intensive care unit use was 
associated with greater use of critical care resources. The pattern among those 
patients admitted to the intensive care unit suggests that hospitals with higher 
utilization may have a lower threshold for admitting patients. These findings 
identify an opportunity to improve intensive care unit use through optimizing 
triage decisions and determining which patients truly derive benefit from the 
intensive care setting.  
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